West Pharmaceutical Services (WST) Share-based Compensation (2012 - 2026)

West Pharmaceutical Services has disclosed Share-based Compensation across 15 years of filings, most recently posting $6.6 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $6.6 million, up 407.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.1 million (up 94.0% YoY), and the FY2025 annual result was $23.8 million, up 27.27% from the prior year.
• Share-based Compensation came in at $6.6 million for Q1 2026 at West Pharmaceutical Services, down from $6.7 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $8.5 million in Q1 2023 to a low of $1.3 million in Q1 2025.
• The 5-year median for Share-based Compensation is $5.9 million (2023), against an average of $5.7 million.
• Across the five-year window, Share-based Compensation tumbled 79.1% in 2023 and soared 407.69% in 2026, its largest moves.
• West Pharmaceutical Services' Share-based Compensation stood at $6.7 million in 2022, then tumbled by 79.1% to $1.4 million in 2023, then soared by 207.14% to $4.3 million in 2024, then soared by 55.81% to $6.7 million in 2025, then decreased by 1.49% to $6.6 million in 2026.
• The last three Share-based Compensation figures came in at $6.6 million (Q1 2026), $6.7 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.